Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study-Reference-Cited by-同舟云学术

Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study

Published:2011-10-14 Issue:11 Volume:65 Page:1193-1199
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:

Author:

Chung M. S.,Lee S. H.,Park K. K.,Yoo S. J.,Chung B. H.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-1241.2011.02759.x/fullpdf

Reference21 articles.

1. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia;Debruyne;Eur Urol,1998

2. Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia;Fulton;Drugs,1995

3. Alpha blockers: are all created equal?;Debruyne;Urology,2000

4. Efficacy and safety of the alpha-1 blocker doxazosin in the treatment of benign prostatic hyperplasia. Analysis of 5 studies;Janknegt;Eur Urol,1993

5. Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo- controlled, dose-response multicenter study;Gillenwater;J Urol,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of α1‐blockers in the current management of hypertension;The Journal of Clinical Hypertension;2022-09

2. Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia;Medicine;2021-08-20

3. Statins are effective in the treatment of benign prostatic hyperplasia with metabolic syndrome;The Aging Male;2018-11-21

4. The association of endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with responsiveness to a selective α1-blocker in men with benign prostatic hyperplasia related lower urinary tract symptoms;BJU International;2016-03-31

5. Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study;Türk Üroloji Dergisi/Turkish Journal of Urology;2015-09-08